miRagen Therapeutics
Viridian Therapeutics is a biotechnology company advancing new treatments for patients with diseases that are underserved by today’s therapies. Viridian is developing multiple product candidates to treat patients who suffer from thyroid eye disease (TED), a debilitating orphan disease, and has early-stage programs focused on other targets and indications.
LifesciencesBioTech
Boulder, CO
$25M-100M
Funding
11-50
Employees
Company Mission
miRagen Therapeutics, Inc., (NASDAQ: MGEN), is a biopharmaceutical company discovering and developing innovative microRNA (miRNA)-targeting therapies to improve human health, specifically in disease areas of high unmet medical need.
Looking for a better job?
Discover the best career opportunities with the best company cultures for you.
Do you work at this company?
Connect your business to thousands of engaged professionals in your city and beyond.
